Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (101-110 of 270) with videos related to

Pageof 27
Sort By:
Open Forum Infectious Diseases|March 22, 2019
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized TrialJonathan Z Li, Paul E Sax, Vincent C Marconi, et al.
The Journal of Infectious Diseases|November 8, 2024
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment InterruptionGesham Magombedze, Elena Vendrame, Devi SenGupta, et al.
Open Forum Infectious Diseases|October 2, 2025
Intact and Defective HIV Provirus Changes During Antiretroviral Therapy in People Treated During Acute or Chronic HIV Infection or as HIV ControllersRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
AIDS Research and Human Retroviruses|March 24, 2022
Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker StudyKarine Dubé, Shadi Eskaf, Liz Barr, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Open Forum Infectious Diseases|April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographicsJonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitnessLeonid Yurkovetskiy, Shawn Egri, Chaitanya Kurhade, et al.
Journal of Neurovirology|March 1, 2017
Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in NigeriaJibreel Jumare, Sara Sunshine, Hayat Ahmed, et al.
Lab on a Chip|July 14, 2017
Rapid, label-free CD4 testing using a smartphone compatible deviceManoj Kumar Kanakasabapathy, Hardik J Pandya, Mohamed Shehata Draz, et al.
Pageof 27

Showing results (101-110 of 270) with videos related to

Sort By:
Pageof 27
Open Forum Infectious Diseases|March 22, 2019
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized TrialJonathan Z Li, Paul E Sax, Vincent C Marconi, et al.
The Journal of Infectious Diseases|November 8, 2024
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment InterruptionGesham Magombedze, Elena Vendrame, Devi SenGupta, et al.
Open Forum Infectious Diseases|October 2, 2025
Intact and Defective HIV Provirus Changes During Antiretroviral Therapy in People Treated During Acute or Chronic HIV Infection or as HIV ControllersRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
AIDS Research and Human Retroviruses|March 24, 2022
Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker StudyKarine Dubé, Shadi Eskaf, Liz Barr, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Open Forum Infectious Diseases|April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographicsJonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitnessLeonid Yurkovetskiy, Shawn Egri, Chaitanya Kurhade, et al.
Journal of Neurovirology|March 1, 2017
Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in NigeriaJibreel Jumare, Sara Sunshine, Hayat Ahmed, et al.
Lab on a Chip|July 14, 2017
Rapid, label-free CD4 testing using a smartphone compatible deviceManoj Kumar Kanakasabapathy, Hardik J Pandya, Mohamed Shehata Draz, et al.
Pageof 27